Over a six‑month trial, a Wired reviewer found that AlterMe’s smart ring and accompanying app helped build better fitness habits, but the genetic insights it promised were underwhelming.

AlterMe markets a wearable that tracks activity, sleep, and heart‑rate data and pairs it with a mobile app that claims to use DNA analysis to suggest personalized workouts and nutrition plans. In the Wired review, the ring’s sensors reliably recorded daily movement and sleep patterns, and the app’s habit‑tracking features nudged the user toward more consistent exercise. However, the reviewer noted that the DNA‑based recommendations rarely offered new or actionable guidance beyond what could be gleaned from the raw sensor data.

This outcome mirrors a growing skepticism about the practical value of DNA‑driven fitness advice. While many companies tout genetic profiling as the next frontier in personal health, independent evaluations often reveal a gap between marketing claims and real‑world benefit. The review serves as a cautionary note for consumers who may be tempted to invest in expensive wearables that promise deep biological insight but deliver only marginal gains in behavior change.

As the market for personalized fitness technology expands, developers and users alike will need to weigh the promise of genetic data against its proven impact. Clearer evidence of how DNA can meaningfully inform training and diet plans will be essential if these products are to justify their cost and maintain consumer trust.